H.-U. Meier-Kriesche

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

Kenneth Lamb, Sundus A. Lodhi, H.-U. Meier-Kriesche · American Journal of Transplantation · 2010 · 915 citations

Medicine, Nephrology, Surgery +16

Immunosuppression: Evolution in Practice and Trends, 1994–2004

H.-U. Meier-Kriesche, S. Li, Rainer W.G. Gruessner et al. · American Journal of Transplantation · 2006 · 558 citations · Full text

Pharmacy, Immunology, Clinical Immunology +11

Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial

Robert S. Gaston, Bruce Kaplan, T. Shah et al. · American Journal of Transplantation · 2009 · 189 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +7

Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study

Antoine Dürrbach, Sander Florman, María del Carmen Rial et al. · American Journal of Transplantation · 2016 · 155 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies

Robert A. Bray, Howard M. Gebel, Robert Townsend et al. · American Journal of Transplantation · 2018 · 131 citations · Full text

Life Sciences, Immunology, Pharmacology +17